annual EBIT:
-$279.30M-$65.24M(-30.48%)Summary
- As of today (July 1, 2025), XENE annual earnings before interest & taxes is -$279.30 million, with the most recent change of -$65.24 million (-30.48%) on December 31, 2024.
- During the last 3 years, XENE annual EBIT has fallen by -$200.31 million (-253.57%).
- XENE annual EBIT is now -2409.01% below its all-time high of $12.10 million, reached on December 31, 2013.
Performance
XENE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$72.74M+$4.74M(+6.12%)Summary
- As of today (July 1, 2025), XENE quarterly earnings before interest & taxes is -$72.74 million, with the most recent change of +$4.74 million (+6.12%) on March 31, 2025.
- Over the past year, XENE quarterly EBIT has dropped by -$13.70 million (-23.20%).
- XENE quarterly EBIT is now -939.83% below its all-time high of $8.66 million, reached on September 30, 2014.
Performance
XENE quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$293.00M-$13.70M(-4.90%)Summary
- As of today (July 1, 2025), XENE TTM earnings before interest & taxes is -$293.00 million, with the most recent change of -$13.70 million (-4.90%) on March 31, 2025.
- Over the past year, XENE TTM EBIT has dropped by -$68.95 million (-30.78%).
- XENE TTM EBIT is now -2255.48% below its all-time high of $13.59 million, reached on September 30, 2014.
Performance
XENE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XENE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.5% | -23.2% | -30.8% |
| 3 y3 years | -253.6% | -318.8% | -264.9% |
| 5 y5 years | -595.0% | -916.6% | -994.0% |
XENE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -253.6% | at low | -139.9% | +6.1% | -232.5% | at low |
| 5 y | 5-year | -876.2% | at low | <-9999.0% | +6.1% | -994.0% | at low |
| alltime | all time | -2409.0% | at low | -939.8% | +6.1% | -2255.5% | at low |
XENE EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$72.74M(-6.1%) | -$293.00M(+4.9%) |
| Dec 2024 | -$279.30M(+30.5%) | -$77.48M(+5.2%) | -$279.30M(+9.3%) |
| Sep 2024 | - | -$73.68M(+6.6%) | -$255.52M(+7.6%) |
| Jun 2024 | - | -$69.10M(+17.0%) | -$237.52M(+6.0%) |
| Mar 2024 | - | -$59.04M(+10.0%) | -$224.04M(+4.7%) |
| Dec 2023 | -$214.05M(+65.7%) | -$53.70M(-3.6%) | -$214.05M(+5.1%) |
| Sep 2023 | - | -$55.68M(+0.1%) | -$203.69M(+9.4%) |
| Jun 2023 | - | -$55.62M(+13.4%) | -$186.13M(+15.7%) |
| Mar 2023 | - | -$49.05M(+13.2%) | -$160.82M(+24.5%) |
| Dec 2022 | -$129.14M(+63.5%) | -$43.33M(+13.6%) | -$129.14M(+16.7%) |
| Sep 2022 | - | -$38.13M(+25.8%) | -$110.65M(+25.6%) |
| Jun 2022 | - | -$30.32M(+74.5%) | -$88.12M(+9.7%) |
| Mar 2022 | - | -$17.37M(-30.1%) | -$80.30M(+1.7%) |
| Dec 2021 | -$78.99M(+176.1%) | -$24.84M(+59.2%) | -$78.99M(+18.8%) |
| Sep 2021 | - | -$15.60M(-30.7%) | -$66.49M(+10.9%) |
| Jun 2021 | - | -$22.50M(+40.1%) | -$59.95M(+59.8%) |
| Mar 2021 | - | -$16.06M(+30.2%) | -$37.51M(+31.1%) |
| Dec 2020 | -$28.61M(-28.8%) | -$12.34M(+36.2%) | -$28.61M(+4.7%) |
| Sep 2020 | - | -$9.06M(>+9900.0%) | -$27.34M(+2.1%) |
| Jun 2020 | - | -$60.00K(-99.2%) | -$26.78M(-26.4%) |
| Mar 2020 | - | -$7.16M(-35.3%) | -$36.39M(-9.4%) |
| Dec 2019 | -$40.18M | -$11.06M(+30.1%) | -$40.18M(+7.6%) |
| Sep 2019 | - | -$8.50M(-12.1%) | -$37.34M(-12.2%) |
| Jun 2019 | - | -$9.67M(-11.6%) | -$42.55M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$10.95M(+33.1%) | -$40.49M(+22.2%) |
| Dec 2018 | -$33.13M(+7.9%) | -$8.22M(-40.0%) | -$33.13M(+0.5%) |
| Sep 2018 | - | -$13.71M(+80.2%) | -$32.97M(+22.1%) |
| Jun 2018 | - | -$7.61M(+112.3%) | -$27.00M(-1.0%) |
| Mar 2018 | - | -$3.58M(-55.6%) | -$27.28M(-13.9%) |
| Dec 2017 | -$30.70M(+23.7%) | -$8.06M(+4.2%) | -$31.69M(+8.9%) |
| Sep 2017 | - | -$7.74M(-1.9%) | -$29.08M(+1.4%) |
| Jun 2017 | - | -$7.89M(-1.2%) | -$28.67M(+5.6%) |
| Mar 2017 | - | -$7.99M(+46.2%) | -$27.15M(+9.4%) |
| Dec 2016 | -$24.82M(+165.1%) | -$5.46M(-25.5%) | -$24.82M(+13.0%) |
| Sep 2016 | - | -$7.33M(+15.2%) | -$21.96M(+42.2%) |
| Jun 2016 | - | -$6.37M(+12.5%) | -$15.45M(+73.9%) |
| Mar 2016 | - | -$5.66M(+117.4%) | -$8.88M(-5.1%) |
| Dec 2015 | -$9.36M(-184.3%) | -$2.60M(+217.4%) | -$9.36M(+39.2%) |
| Sep 2015 | - | -$820.00K(-512.1%) | -$6.72M(-343.8%) |
| Jun 2015 | - | $199.00K(-103.2%) | $2.76M(-29.9%) |
| Mar 2015 | - | -$6.14M(<-9900.0%) | $3.94M(-64.6%) |
| Dec 2014 | $11.11M(-8.2%) | $35.00K(-99.6%) | $11.11M(-18.3%) |
| Sep 2014 | - | $8.66M(+528.5%) | $13.59M(+20.0%) |
| Jun 2014 | - | $1.38M(+33.5%) | $11.32M(+13.9%) |
| Mar 2014 | - | $1.03M(-59.1%) | $9.95M(+11.6%) |
| Dec 2013 | $12.10M(-387.5%) | $2.52M(-60.6%) | $8.91M(+39.4%) |
| Sep 2013 | - | $6.39M | $6.39M |
| Dec 2012 | -$4.21M(-64.6%) | - | - |
| Dec 2011 | -$11.90M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual EBIT year-on-year change?
- What is Xenon Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly EBIT year-on-year change?
- What is Xenon Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM EBIT year-on-year change?
What is Xenon Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of XENE is -$279.30M
What is the all time high annual EBIT for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual earnings before interest & taxes is $12.10M
What is Xenon Pharmaceuticals annual EBIT year-on-year change?
Over the past year, XENE annual earnings before interest & taxes has changed by -$65.24M (-30.48%)
What is Xenon Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of XENE is -$72.74M
What is the all time high quarterly EBIT for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly earnings before interest & taxes is $8.66M
What is Xenon Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, XENE quarterly earnings before interest & taxes has changed by -$13.70M (-23.20%)
What is Xenon Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of XENE is -$293.00M
What is the all time high TTM EBIT for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM earnings before interest & taxes is $13.59M
What is Xenon Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, XENE TTM earnings before interest & taxes has changed by -$68.95M (-30.78%)